Last update 08 May 2025

Compound Xueshuantong Capsule

Overview

Basic Info

Drug Type
Herbal medicine
Synonyms
Compound thrombosis capsule
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesCardiovascular DiseasesEye Diseases
Active Indication
Angina PectorisRetinal Vein OcclusionIschemic stroke
Inactive Indication-
Originator Organization
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Active Organization
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
China (27 Aug 2019),
Angina PectorisRetinal Vein Occlusion
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Compound Xueshuantong Capsule
CTR20170885
/ Not yet recruitingPhase 2
评价复方血栓通胶囊治疗缺血性中风恢复早期（中风中经络-气阴两虚、瘀血阻络证）安全性和有效性Ⅱa期临床试验
[Translation] Phase IIa clinical trial to evaluate the safety and efficacy of Fufang Xueshuantong Capsule in the treatment of early recovery of ischemic stroke (stroke meridian-Qi and Yin deficiency, blood stasis obstruction syndrome)
NCT02465749
/ Not yet recruitingEarly Phase 1IIT
Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa
100 Clinical Results associated with Compound Xueshuantong Capsule
Login to view more data
100 Translational Medicine associated with Compound Xueshuantong Capsule
Login to view more data
100 Patents (Medical) associated with Compound Xueshuantong Capsule
Login to view more data
100 Deals associated with Compound Xueshuantong Capsule
Login to view more data

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Angina Pectoris
China
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Guangdong Zhongsheng Pharmaceutical Co., Ltd.
27 Aug 2019
Retinal Vein Occlusion
China
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Guangdong Zhongsheng Pharmaceutical Co., Ltd.
27 Aug 2019
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Ischemic strokePhase 2
China
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Guangdong Zhongsheng Pharmaceutical Co., Ltd.
11 Aug 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free